Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth
Tandem Diabetes Care Inc (NASDAQ:TNDM) posted Q1 losses of $(0.23) deeper than $(0.08) posted a year ago and missing the consensus of $(0.07). Sales increased 25% to $175.91 million, beating the consensus of $168.43 million. Worldwide pump shipments increased 11% Y/Y to 28,095. The gross margin remained almost unchanged at 52%. The company…
Benzinga ·
Benzinga
